Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Ophthalmic Drug Delivery Systems01:23

Ophthalmic Drug Delivery Systems

283
Ophthalmic drug delivery faces major limitations due to poor absorption across the corneal membrane. This process is primarily driven by diffusion and is influenced by two main factors: the physicochemical properties of the drug and tear drainage. Most ophthalmic drugs, such as pilocarpine, epinephrine, atropine, and local anesthetics, are weak bases. They are typically formulated at an acidic pH to enhance chemical stability. However, this leads to high ionization, reducing their ability to...
283
Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

1.1K
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
1.1K
Glaucoma: Overview01:25

Glaucoma: Overview

1.7K
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
1.7K
Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

1.6K
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
1.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Congenital cataracts in females caused by BCOR mutations; report of six further families demonstrating clinical variability and diverse genetic mechanisms.

European journal of medical genetics·2019
Same author

Diagnosing the cause of bilateral paediatric cataracts: comparison of standard testing with a next-generation sequencing approach.

Eye (London, England)·2016
Same author

A novel mutation in IL36RN underpins childhood pustular dermatosis.

Journal of the European Academy of Dermatology and Venereology : JEADV·2015
Same author

3-M syndrome: a growth disorder associated with IGF2 silencing.

Endocrine connections·2013
Same author

Mutations in CUL7, OBSL1 and CCDC8 in 3-M syndrome lead to disordered growth factor signalling.

Journal of molecular endocrinology·2012
Same author

MRSA and cataract surgery - reflections for practice.

Clinical ophthalmology (Auckland, N.Z.)·2010
Same journal

A Second Report of a Missense Variant in AMMECR1 Causing Midface Hypoplasia, Hearing Impairment, Elliptocytosis, and Nephrocalcinosis: Case Report and Literature Review.

Clinical genetics·2026
Same journal

From Pathogenicity to Mechanism: A Variant Interpretation Framework for Monogenic Epilepsy.

Clinical genetics·2026
Same journal

Biallelic Variants in ATP1A4 Are Associated with Oligoasthenoteratozoospermia and Male Infertility.

Clinical genetics·2026
Same journal

Diagnostic Yield and Clinical Impact of Comprehensive WES/WGS Testing Beyond Common Genetic Causes in Hereditary Optic Atrophy.

Clinical genetics·2026
Same journal

Further Support of Autosomal Recessive CSF3-Related Severe Congenital Neutropenia.

Clinical genetics·2026
Same journal

Biallelic TMEM126B Variants as a Novel Cause of Kidney Failure-Implications for Mitochondrial Genetic Testing in Nephrology: A Response Letter.

Clinical genetics·2026
See all related articles

Related Experiment Video

Updated: May 1, 2026

Integrated Photoacoustic Ophthalmoscopy and Spectral-domain Optical Coherence Tomography
11:21

Integrated Photoacoustic Ophthalmoscopy and Spectral-domain Optical Coherence Tomography

Published on: January 15, 2013

10.9K

Personalized ophthalmology.

L F Porter1, G C M Black

  • 1Centre for Genomic Medicine, Institute of Human Development, Faculty of Medical and Human Sciences, University of Manchester, Manchester Academic Health Science Centre (MAHSC), Saint Mary's Hospital, Manchester, UK; Manchester Royal Eye Hospital, Department of Ophthalmology, Manchester, UK.

Clinical Genetics
|March 27, 2014
PubMed
Summary
This summary is machine-generated.

Personalized ophthalmology uses genetic technologies for diagnosing and treating eye diseases. This approach offers gene replacement therapies and improved management for conditions like age-related macular degeneration.

Keywords:
gene therapygeneticsgenomicsinherited eye diseasemolecular diagnosisnext-generation sequencingpersonalized medicinepersonalized ophthalmologytargeted therapies

More Related Videos

Customizing a Cryolite Glass Prosthetic Eye
08:04

Customizing a Cryolite Glass Prosthetic Eye

Published on: October 31, 2019

10.4K
Author Spotlight: Anterior HR-OCT as a Non-Invasive Tool for Characterizing Ocular Surface Squamous Neoplasia
06:15

Author Spotlight: Anterior HR-OCT as a Non-Invasive Tool for Characterizing Ocular Surface Squamous Neoplasia

Published on: August 9, 2024

1.7K

Related Experiment Videos

Last Updated: May 1, 2026

Integrated Photoacoustic Ophthalmoscopy and Spectral-domain Optical Coherence Tomography
11:21

Integrated Photoacoustic Ophthalmoscopy and Spectral-domain Optical Coherence Tomography

Published on: January 15, 2013

10.9K
Customizing a Cryolite Glass Prosthetic Eye
08:04

Customizing a Cryolite Glass Prosthetic Eye

Published on: October 31, 2019

10.4K
Author Spotlight: Anterior HR-OCT as a Non-Invasive Tool for Characterizing Ocular Surface Squamous Neoplasia
06:15

Author Spotlight: Anterior HR-OCT as a Non-Invasive Tool for Characterizing Ocular Surface Squamous Neoplasia

Published on: August 9, 2024

1.7K

Area of Science:

  • Genetics and Ophthalmology
  • Genomic Medicine
  • Ophthalmic Research

Background:

  • Ophthalmology is an early adopter of personalized medicine, leveraging genomic advances.
  • Molecular diagnosis, including next-generation sequencing, is crucial for developing novel therapies.

Purpose of the Study:

  • To review the clinical implications of personalized ophthalmology.
  • To discuss disease stratification and individualization in patient management.
  • To explore the potential of genetic technologies in revolutionizing eye care.

Main Methods:

  • Review of current literature on genetic technologies in ophthalmology.
  • Analysis of disease stratification through phenotypic and genetic assessment.
  • Examination of individualization strategies in patient management.

Main Results:

  • Gene replacement therapies are emerging for monogenic eye diseases.
  • Personalized approaches promise to alter prediction, diagnosis, and management of complex diseases like age-related macular degeneration.
  • Genetic testing offers advantages for patients with inherited eye diseases.

Conclusions:

  • Personalized ophthalmology, driven by molecular understanding, has the potential to revolutionize the field.
  • Key areas for adoption include disease stratification and individualization of patient care.
  • Ethical considerations and future challenges must be addressed for successful implementation.